NCT06329414Withdrawn
Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 6 Nov 2026
Brief summary (registry, in English)
The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated questionnaires and exams before, during, and after treatment.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 15 Mar 2024
- Start date
- 16 Jan 2024
- Primary completion date
- 10 Jan 2025
- Lead sponsor
- University of Utah
- Diseases
- Multiple sclerosis, Depression
- NCT number
- NCT06329414
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- MS relapse and/or steroid use within 3 months
Other illness
- History of seizure/epilepsy, brain tumor, or stroke
- History of bipolar disorder or psychosis
Other
- Active suicidal ideation
- Currently or planning to become pregnant
Who the study is looking for
- Established diagnosis of multiple sclerosis (any subtype) by 2017 McDonald criteria
- Established diagnosis of major depressive disorder (MDD) by DSM-5 criteria
- Eligible for transcranial magnetic stimulation (rTMS) for depression
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Of Utah Health | Salt Lake City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.